107 related articles for article (PubMed ID: 26558681)
1. MK2 Deletion in Mice Prevents Diabetes-Induced Perturbations in Lipid Metabolism and Cardiac Dysfunction.
Ruiz M; Coderre L; Lachance D; Houde V; Martel C; Thompson Legault J; Gillis MA; Bouchard B; Daneault C; Carpentier AC; Gaestel M; Allen BG; Des Rosiers C
Diabetes; 2016 Feb; 65(2):381-92. PubMed ID: 26558681
[TBL] [Abstract][Full Text] [Related]
2. Protecting the heart through MK2 modulation, toward a role in diabetic cardiomyopathy and lipid metabolism.
Ruiz M; Coderre L; Allen BG; Des Rosiers C
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1914-1922. PubMed ID: 28735097
[TBL] [Abstract][Full Text] [Related]
3. Streptozotocin diabetes increases mRNA expression of ketogenic enzymes in the rat heart.
Cook GA; Lavrentyev EN; Pham K; Park EA
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):307-312. PubMed ID: 27845231
[TBL] [Abstract][Full Text] [Related]
4. Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy.
Park JK; Ronkina N; Höft A; Prohl C; Menne J; Gaestel M; Haller H; Meier M
Nephrol Dial Transplant; 2008 Jun; 23(6):1844-53. PubMed ID: 18182404
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia and hyperlipidemia blunts the Insulin-Inpp5f negative feedback loop in the diabetic heart.
Bai D; Zhang Y; Shen M; Sun Y; Xia Q; Zhang Y; Liu X; Wang H; Yuan L
Sci Rep; 2016 Feb; 6():22068. PubMed ID: 26908121
[TBL] [Abstract][Full Text] [Related]
7. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
[TBL] [Abstract][Full Text] [Related]
8. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
9. p53 promotes cardiac dysfunction in diabetic mellitus caused by excessive mitochondrial respiration-mediated reactive oxygen species generation and lipid accumulation.
Nakamura H; Matoba S; Iwai-Kanai E; Kimata M; Hoshino A; Nakaoka M; Katamura M; Okawa Y; Ariyoshi M; Mita Y; Ikeda K; Okigaki M; Adachi S; Tanaka H; Takamatsu T; Matsubara H
Circ Heart Fail; 2012 Jan; 5(1):106-15. PubMed ID: 22075967
[TBL] [Abstract][Full Text] [Related]
10. MARK4 aggravates cardiac dysfunction in mice with STZ-induced diabetic cardiomyopathy by regulating ACSL4-mediated myocardial lipid metabolism.
Wu Y; Zhang J; Wang W; Wu D; Kang Y; Fu L
Sci Rep; 2024 Jun; 14(1):12978. PubMed ID: 38839927
[TBL] [Abstract][Full Text] [Related]
11. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.
Amrutkar M; Cansby E; Chursa U; Nuñez-Durán E; Chanclón B; Ståhlman M; Fridén V; Mannerås-Holm L; Wickman A; Smith U; Bäckhed F; Borén J; Howell BW; Mahlapuu M
Diabetes; 2015 Aug; 64(8):2791-804. PubMed ID: 25845663
[TBL] [Abstract][Full Text] [Related]
12. Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice.
Ma B; Xiong X; Chen C; Li H; Xu X; Li X; Li R; Chen G; Dackor RT; Zeldin DC; Wang DW
Endocrinology; 2013 Aug; 154(8):2843-56. PubMed ID: 23696562
[TBL] [Abstract][Full Text] [Related]
13. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
14. Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes.
Huang TH; Yang Q; Harada M; Uberai J; Radford J; Li GQ; Yamahara J; Roufogalis BD; Li Y
Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):78-85. PubMed ID: 16129467
[TBL] [Abstract][Full Text] [Related]
15. JNK deficiency enhances fatty acid utilization and diverts glucose from oxidation to glycogen storage in cultured myotubes.
Vijayvargia R; Mann K; Weiss HR; Pownall HJ; Ruan H
Obesity (Silver Spring); 2010 Sep; 18(9):1701-9. PubMed ID: 20094041
[TBL] [Abstract][Full Text] [Related]
16. Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy.
Pulinilkunnil T; Kienesberger PC; Nagendran J; Waller TJ; Young ME; Kershaw EE; Korbutt G; Haemmerle G; Zechner R; Dyck JR
Diabetes; 2013 May; 62(5):1464-77. PubMed ID: 23349479
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of sodium tungstate improves cardiac performance in streptozotocin-induced diabetic rats.
Nagareddy PR; Vasudevan H; McNeill JH
Can J Physiol Pharmacol; 2005 May; 83(5):405-11. PubMed ID: 15897922
[TBL] [Abstract][Full Text] [Related]
18. TAX1BP1 overexpression attenuates cardiac dysfunction and remodeling in STZ-induced diabetic cardiomyopathy in mice by regulating autophagy.
Xiao Y; Wu QQ; Duan MX; Liu C; Yuan Y; Yang Z; Liao HH; Fan D; Tang QZ
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1728-1743. PubMed ID: 29476905
[TBL] [Abstract][Full Text] [Related]
19. Reduction of insulin signaling upregulates angiopoietin-like protein 4 through elevated free fatty acids in diabetic mice.
Mizutani N; Ozaki N; Seino Y; Fukami A; Sakamoto E; Fukuyama T; Sugimura Y; Nagasaki H; Arima H; Oiso Y
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):139-44. PubMed ID: 22068616
[TBL] [Abstract][Full Text] [Related]
20. Role of lipids in the early developmental stages of experimental immune diabetes induced by multiple low-dose streptozotocin.
Pighin D; Karabatas L; Pastorale C; Dascal E; Carbone C; Chicco A; Lombardo YB; Basabe JC
J Appl Physiol (1985); 2005 Mar; 98(3):1064-9. PubMed ID: 15703165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
